FranceMed Pharma is a privately owned British company, with solid base in, London, UK, since established in 1981. Active in patented, progressive, pioneering work in Medical Devices and FMCG, mainly related to:
Discovery/R&D/ Synthesis/ Screening/ Pre-Clinical/ Clinical (Phase I, II and III), MHRA Registration, Manufacturing, Sales, Marketing.
Its unique, Therapeutic Class 1 Medical Devices, developed over the last four decades, are available in the UK and Export markets.
In the UK, the range is available from doctors via the NHS prescription re-imbursement scheme as well as High Street pharmacies.
FranceMed Pharma is the sole global manufacturer of its range of products.
FranceMed Pharma’s micro-fine topical sprays are the World's ONLY sprays that employ a Disruptive Unique patented Technology that works in seconds to stop itch, pain, burning, stinging with long lasting effect, setting a new Gold Standard for treating various conditions and symptoms.
Commercially classified as Greenfield products with No Competition, No Me-Too's and No Generics. Its Discovery “Instant T-CNS Signalling System”™ disruptive delivery technology allows a number of stimuli e.g. chemical, thermal and mechanical to be applied topically and simultaneously on the affected areas achieving greater efficacy than when applying each stimulus in turn. The efficacy is not just symptomatic as repetitive use is clinically proven to reduce or treat the underlying condition with no side effects.